Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
about
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopHow I treat autoimmune lymphoproliferative syndromeApproaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative SyndromeDecitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivoNF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppressionAutoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosisUpdated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Elevated double negative T cells in pediatric autoimmunitySomatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisOnset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulationGene defects in the soma: some get it and some don't!Clues to immune tolerance: the monogenic autoimmune syndromesGenomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosusIL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndromeAltered differentiation, diminished pathogenicity, and regulatory activity of myelin-specific T cells expressing an enhanced affinity TCR.The expanding spectrum of the autoimmune lymphoproliferative syndromesSirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis.Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.Diagnosis of autoimmune lymphoproliferative syndrome caused by FAS deficiency in adults.Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia.Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutationNatural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutationsCD95-mediated cell signaling in cancer: mutations and post-translational modulations.The importance of p53 pathway genetics in inherited and somatic cancer genomes.Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance.Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies.Isolation of double negative αβ T cells from the kidney.
P2860
Q24632569-8A66B73F-AA26-457E-A1C5-2C99B72AFB84Q24633207-B187DA42-993E-4B1C-AE38-F069978E0323Q26799956-1714ACA6-0A60-491E-BFC2-A2B4EAE12C1FQ28263221-FEAA13EB-F0B4-43F8-88F2-90C0C25A48E2Q28268202-791CA238-E254-45D6-960B-35A3ACD24046Q28299956-035A4439-033D-4968-8F84-BAD3CA6F7AD9Q33420245-70253050-EA28-4C83-87E6-8EAFE60B173BQ33717456-2ADA8D49-FEC9-45EB-A80E-345CF1EFC2F9Q34149957-ABFC2CDF-A49A-4D4D-AFFF-F31478D1EAD2Q34428954-BC6F2B9B-AB14-4B00-93B8-267956F5871DQ34429062-D2C159B8-4FED-4F37-9233-020EED73772AQ34440616-81D3589E-4324-4CF2-B71B-25462DFE3F0BQ34672353-299CB9C7-D429-4B53-BBE4-C30892058D3EQ35130847-243A52A4-B945-4F89-88BB-1514B001B449Q35566596-416EF962-5F05-4EF7-A8A8-D694CDF2DF34Q35619447-D8F9694D-DCC2-42B1-AD32-823A8735176FQ36443121-288FFE16-8FFA-4BEA-93EE-B8AA591A0B12Q36595156-F4DA6EFB-1D53-4C8A-BF0A-58A9A2FFC350Q36708937-744BECE6-28A9-4DB2-824F-9072000C529EQ36862333-B0A61F34-DE0E-4FA8-A5C8-78AEFE867FA2Q37377927-15A23C3A-BD82-4575-AF56-017C5492CEE3Q37618832-DC8697A2-1B01-4341-A876-3D3191FF0B18Q37670054-FC24F674-5EBB-43BA-86BD-33277C132DCCQ37951369-C8D9657D-041F-41DA-BFB0-F15E1D4972E3Q38786667-24465AA8-F98B-457B-8E20-36015FDB4E7AQ39413664-72495E18-35D8-4B62-A050-382FF9AC796BQ40101187-B4161146-B58E-496E-B0A2-43F2872C6861Q42934700-6F6613A0-A492-4482-9F84-990F88647867
P2860
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@ast
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@en
type
label
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@ast
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@en
prefLabel
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@ast
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@en
P2093
P2860
P1433
P1476
Somatic FAS mutations are comm ...... lymphoproliferative syndrome.
@en
P2093
Jeffrey I Cohen
Jennifer M Puck
Joie Davis
João Bosco Oliveira
Kennichi C Dowdell
Ronald L Hornung
Stefania Pittaluga
Susan Price
Thomas A Fleisher
V Koneti Rao
P2860
P304
P356
10.1182/BLOOD-2010-01-263145
P407
P577
2010-04-01T00:00:00Z